Contact
Please use this form to send email to PR contact of this press release:
Nobilis Therapeutics Receives NIH Award to Study Xenon Inhaler for Rapid Reduction of Opioid Withdrawal Symptoms
TO:
Vlad Bogin, MD, FACP CEO
Nobilis Therapeutics
+1 360-431-4107